Predict your next investment

Cantab Anti-infectives company logo
HEALTHCARE | Biotechnology
cantabanti.com

See what CB Insights has to offer

About Cantab Anti-infectives

Cantab Anti-infectives is focused exclusively on the discovery and development of antibacterial agents to treat bacterial infections. The product pipeline has been derived by optimizing the therapeutic properties of peptide-derived antibiotics, namely lantibiotics and polymyxins. This has been achieved through a combination of molecular engineering at the genetic level together with medicinal chemistry to fully explore the structure-activity relationships of these agents.

Cantab Anti-infectives Headquarter Location

BioPark Hertfordshire Broadwater Road

Welwyn Garden City, England, AL7 3AX,

United Kingdom

+44 01707356132

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cantab Anti-infectives

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cantab Anti-infectives is included in 1 Expert Collection, including Infectious Disease.

I

Infectious Disease

2,222 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.